sporanox i.v. 250mg/25ml solution for infusion ampoules and diluent
janssen-cilag ltd - itraconazole - solution for infusion - 10mg/1ml
itraconazole 10mg/ml oral solution
athlone laboratories ltd - itraconazole - oral solution - 10 milligram(s)/millilitre - triazole derivatives; itraconazole
sporanox 10 mg/ml oral solution
janssen sciences ireland uc - itraconazole - oral solution - 10 milligram(s)/millilitre - triazole derivatives; itraconazole
sporanox i.v. 10 mg/ml concentrate and solvent for solution for infusion
janssen sciences ireland uc - itraconazole - concentrate and solvent for solution for infusion - 10 milligram(s)/millilitre - triazole derivatives; itraconazole
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastic agents - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
tukysa 150 mg
merck sharp & dohme (israel-1996) ltd - tucatinib - film coated tablets - tucatinib 150 mg - tucatinib - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2-positive locally advanced or metastatic breast cancer who have received at least 2 prior anti-her2 treatment regimens.
tukysa 50 mg
merck sharp & dohme (israel-1996) ltd - tucatinib - film coated tablets - tucatinib 50 mg - tucatinib - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2-positive locally advanced or metastatic breast cancer who have received at least 2 prior anti-her2 treatment regimens.
itraconazole 10mg/ml oral solution
athlone pharmaceuticals limited - itraconazole - oral solution - triazole derivatives; itraconazole
sporanox capsule
janssen inc - itraconazole - capsule - 100mg - itraconazole 100mg - azoles
sporanox solution
janssen inc - itraconazole - solution - 10mg - itraconazole 10mg - azoles